Martin Mackay Buys 5,504 Shares of Rallybio Corp (NASDAQ:RLYB) Stock

Rallybio Corp (NASDAQ:RLYB) CEO Martin Mackay acquired 5,504 shares of the stock in a transaction that occurred on Monday, January 10th. The stock was acquired at an average cost of $10.10 per share, for a total transaction of $55,590.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of RLYB stock opened at $8.87 on Friday. Rallybio Corp has a 1-year low of $8.06 and a 1-year high of $25.78. The business’s 50-day moving average is $11.90.

Rallybio (NASDAQ:RLYB) last posted its quarterly earnings results on Wednesday, November 10th. The company reported ($0.37) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.89) by $0.52. As a group, research analysts anticipate that Rallybio Corp will post -2.89 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of RLYB. Viking Global Investors LP purchased a new position in Rallybio in the third quarter valued at approximately $73,744,000. New Leaf Venture Partners L.L.C. acquired a new stake in Rallybio in the third quarter valued at approximately $40,462,000. Sectoral Asset Management Inc acquired a new stake in Rallybio in the third quarter valued at approximately $9,267,000. Laurion Capital Management LP acquired a new stake in Rallybio in the third quarter valued at approximately $7,032,000. Finally, BlackRock Inc. acquired a new stake in Rallybio in the third quarter valued at approximately $5,137,000. Hedge funds and other institutional investors own 94.98% of the company’s stock.

Separately, Zacks Investment Research lowered shares of Rallybio from a “buy” rating to a “hold” rating in a report on Thursday.

Rallybio Company Profile

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

Read More: What does an inverted yield curve signify?

Receive News & Ratings for Rallybio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rallybio and related companies with MarketBeat.com's FREE daily email newsletter.